| Title |
Tranexamic acid for the prevention and management of orthopedic surgical hemorrhage: current evidence
|
|---|---|
| Published in |
Journal of Blood Medicine, August 2015
|
| DOI | 10.2147/jbm.s61915 |
| Pubmed ID | |
| Authors |
Christopher Kim, Sam Si-Hyeong Park, J Roderick Davey |
| Abstract |
Total joint arthroplasty can be associated with major blood loss and require subsequent blood transfusions for postoperative anemia. Measures to effectively and safely decrease blood loss and reduce the need for blood transfusions would help improve patient safety and lower health care costs. A possible pharmacological option to reduce surgical blood loss in total joint arthroplasty is the use of tranexamic acid. Abundant literature has shown that intravenous and/or topical administration of tranexamic acid is effective in reducing blood loss and blood transfusions, with no increased risk of venous thromboembolic events or other complications. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 25% |
| Australia | 1 | 25% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 3 | 75% |
| Members of the public | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 104 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Postgraduate | 15 | 14% |
| Other | 14 | 13% |
| Researcher | 10 | 10% |
| Student > Doctoral Student | 9 | 9% |
| Student > Master | 9 | 9% |
| Other | 23 | 22% |
| Unknown | 24 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 66 | 63% |
| Nursing and Health Professions | 5 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
| Biochemistry, Genetics and Molecular Biology | 1 | <1% |
| Economics, Econometrics and Finance | 1 | <1% |
| Other | 1 | <1% |
| Unknown | 28 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2023.
All research outputs
#8,035,020
of 25,576,275 outputs
Outputs from Journal of Blood Medicine
#106
of 335 outputs
Outputs of similar age
#86,481
of 276,796 outputs
Outputs of similar age from Journal of Blood Medicine
#4
of 5 outputs
Altmetric has tracked 25,576,275 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 335 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.9. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 276,796 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one.